AI assistant
RECTRON — Interim / Quarterly Report 2025
Nov 14, 2025
51998_rns_2025-11-14_a5a43079-2042-4c37-b8ce-c233acfac312.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
1
Stock Code:2302
Rectron Ltd. AND SUBSIDIARIES
Consolidated Financial Statements
With Independent Auditors’ Review Report
For the Nine Months Ended September 30, 2025 and 2024
Address: No. 71, Zhongshan Rd., Tucheng Dist., New Taipei City, Taiwan Telephone:886-2-28801122
The independent auditors’ review report and the accompanying consolidated financial statements are the English translation of the Chinese version prepared and used in the Republic of China. If there is any conflict between, or any difference in the interpretation of the English and Chinese language independent auditors’ review report and consolidated financial statements, the Chinese version shall prevail.
2
Table of contents
Contents 1.Cover Page 2.Table of Contents 3.Independent Auditors’ Review Report 4.Consolidated Balance Sheets 5.Consolidated Statement of Comprehensive Income 6.Consolidated Statement of Changes in Equity 7.Consolidated Statement of Cash Flows 8.Notes to the Consolidated Financial Statements (1) Company history (2)Approval date and procedures of the consolidated financial statements (3) New standards, amendments and interpretations adopted (4)Summary of material accounting policies (5)Significant accounting assumptions and judgments, and major sources of estimation uncertainty (6) Explanation of significant accounts (7) Related-party transactions (8)Assets pledged as security (9) Commitments and contingencies (10)Losses due to major disasters (11)Subsequent events (12)Other (13)Other disclosures Information on significant transactions Information on investees Information on investment in Mainland China (14)Segment information |
Page |
|---|---|
1 2 3 4 5 6 7 8 8 8~9 10~11 11 11~33 33~35 35 35 36 36 36 36~38 38 38~39 39~40 |
Independent Auditors’ Review Report
3
To the Board of Directors of RECTRON LTD. Company :
Introduction
We have reviewed the accompanying consolidated balance sheets of the RECTRON LTD. Company and its subsidiaries as of September 30, 2025 and 2024, and the related consolidated statements of comprehensive income, changes in equity and cash flows for the Nine Months ended September 30, 2025 and 2024, and notes to the consolidated financial statements, including a summary of significant accounting policies. Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34, “Interim Financial Reporting” endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China. Our responsibility is to express a conclusion on the consolidated financial statements based on our reviews.
Scope of Review
Except as explained in the Basis for Qualified Conclusion paragraph, we conducted our reviews in accordance with the Standard on Review Engagements 2410, "Review of Financial Information Performed by the Independent Auditor of the Entity" of the Republic of China. A review of the consolidated financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing of the Republic of China and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Basis for Qualified Conclusion
As stated in Note 4(b), the consolidated financial statements included the financial statements of certain non-significant subsidiaries, which were not reviewed by independent auditors. These financial statements reflect total assets amounting to $337,273 thousand and $211,289 thousand, constituting 13% and 8% of consolidated total assets as of September 30, 2025 and 2024, respectively, total liabilities amounting to $14,300 thousand and $7,646 thousand, constituting 2% and 1% of consolidated total liabilities as of September 30, 2025 and 2024, respectively, and total comprehensive income (loss) amounting to $15,940 thousand, $(4,943)thousand, $(462)thousand and $(7,684) thousand, constituting 25%, (24)%, (1)% and (10)% of consolidated total comprehensive income (loss) for the three months and the Nine Months ended September 30, 2025 and 2024, respectively.
Qualified Conclusion
Except for the adjustments, if any, as might have been determined to be necessary had the financial statements of certain consolidated subsidiaries and equity accounted investee companies described in the Basis for Qualified Conclusion paragraph above been reviewed by independent auditors, based on our reviews, nothing has come to our attention that causes us to believe that the accompanying consolidated financial statements do not present fairly, in all material respects, the consolidated financial position of the RECTRON LTD. Company and its subsidiaries as of September 30, 2025 and 2024, and of its consolidated financial performance and its consolidated cash flows for the Nine Months ended September 30, 2025 and 2024 in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34, “Interim Financial Reporting” endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China
3-1
Other Matters
We did not review the financial statements of certain consolidated subsidiaries, with total assets of $75,232 thousand and $57,181 thousand, representing 3% and 2% of the related consolidated total assets as of September 30, 2025 and 2024, and net sales of $567 thousand, $843 thousand, $2,221 thousand and $1,667 thousand, representing 0%, 0%, 0% and 0% of the related consolidated total net sales for the three months and the Nine Months ended September 30, 2025 and 2024, respectively. Those financial statements were reviewed by other auditors whose reports have been furnished to us, and our review, insofar as it relates to the amounts included for certain consolidated subsidiaries, are based solely on the reports of the other auditors.
The engagement partners on the reviews resulting in this independent auditors’ review report are Shih-Chin Chih and Hsin-Ting Huang.
KPMG
Taipei, Taiwan (Republic of China) November 13, 2025
Notes to Readers
The accompanying consolidated financial statements are intended only to present the consolidated financial position, financial performance and its cash flows in accordance with the accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to review such consolidated financial statements are those generally accepted and applied in the Republic of China.
The independent auditors’ review report and the accompanying consolidated financial statements are the English translation of the Chinese version prepared and used in the Republic of China. If there is any conflict between, or any difference in the interpretation of the English and Chinese language independent auditors’ review report and consolidated financial statements, the Chinese version shall prevail.
4
(English Translation of Consolidated Financial Statements Originally Issued in Chinese.) Rectron LTD. and Subsidiaries
Consolidated Balance Sheets
September 30, 2025, December 31 and September 30, 2024 (Expressed in Thousands of New Taiwan Dollar)
| Assets Current assets: 1100 Cash and cash equivalents (note 6(a)) 1110 Current financial assets at fair value through profit or loss (note 6(b)) 1136 Current financial assets at amortized cost (note 6(c)) 1150 Trade notes receivable net (note 6(d) and (o)) 1170 Trade receivables net (note 6(d), (o) and 7) 1200 Other receivables 1220 Total current tax assets 130X Inventories (note 6(e)) 1410 Prepayments(note 7) 1479 Other current assets Non-current assets: 1517 Non-current financial assets at fair value through other comprehensive income (note 6(b)) 1600 Property, plant and equipment (note 6(f), 8 and 9) 1755 Right-of-use assets (note 6(g), and 9) 1760 Investment property (note 6(h) , 7, 8 and 9) 1990 Other non-current assets (note 6(d)) Total assets |
September 30, 2025 Amount % 405,527 16 222,272 9 12,107 457 - 168,306 7 8,689 - 17 - 143,857 6 12,133 - 4,3583 - 977,723 38 41,390 2 572,270 22 24,014 1 940,230 37 2,006 - 1,579,910 62 2,557,6337 100 |
December 31, 2024 | December 31, 2024 | September 30, 2024 Amount % 631,770 24 16,186 1 310 - 134,056 5 3,021 - 436 - 123,534 5 15,130 1 3,724 - 928,167 36 57,734 2 636,483 24 16,797 1 958,780 37 2,793 - 1,672,587 64 2,600,754 100 Liabilities and Equity Current liabilities: 2100 Short-term borrowings (note 6(i)) 2130 Current contract liabilities (note 6(o)) 2170 Trade payables 2200 Other payables (note 7 and 9 ) 2230 Current tax liabilities 2280 Current lease liabilities (note 7 ) 2300 Other current liabilities (note 9 ) Non-current liabilities 2580 Non-current lease liabilities(note 7 ) 2640 Net defined benefit liability, non- current (note 6(k)) 2570 Deferred tax liabilities (note 6(l)) 2600 Other non-current liabilities (note 7 ) Total liabilities Equity (notes 6(m)): 3110 Ordinary shares 3200 Capital surplus 3310 Legal reserve 3320 Special reserve 3351 Retained earnings 3400 Other equity Total equity Total liabilities and equity |
September 30, 2025 Amount % $ - - 99 - 143,651 6 46,886 2 8,087 - 3,255 - 487,721 19 689,699 27 1,901 - 3 - 68.023 3 4,792 - 74,719 3 764,418 3 0 1,663,029 65 9 - 73,269 3 103,296 4 70,414 3 (116,802 ) (5) 1,793,215 70 $ 2,557,633 100 |
September 30, 2025 Amount % $ - - 99 - 143,651 6 46,886 2 8,087 - 3,255 - 487,721 19 689,699 27 1,901 - 3 - 68.023 3 4,792 - 74,719 3 764,418 3 0 1,663,029 65 9 - 73,269 3 103,296 4 70,414 3 (116,802 ) (5) 1,793,215 70 $ 2,557,633 100 |
December 31, 2024 Amount % - - 38 - 131,353 5 219,520 8 16,994 1 3,330 - 364,004 14 735,239 28 4,570 - 84 - 67,201 3 4,653 - 76,508 3 811,747 31 1,663,029 63 9 - 60,655 2 87,143 3 126,496 5 (103,296)) (4) 1,834,036 69 2,645,783 100 |
September 30, 2024 | September 30, 2024 | September 30, 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amount $ - 99 143,651 46,886 8,087 3,255 487,721 689,699 1,901 3 68.023 4,792 74,719 764,418 1,663,029 9 73,269 103,296 70,414 (116,802 ) |
Amount % $ 3,000 - 1,221 - 126,668 5 215,563 8 7,709 - 2,869 - 366,352 15 723,382 28 5,634 - 1,076 - 62,684 3 4,752 - 74,146 3 797,528 31 1,663,029 64 9 - 60,655 2 87,143 3 63,834 3 (71,444) (3) 1,803,226 69 $ 2,600,754 100 |
|||||||||||
| $ $ | Amount % 564,394 21 132,575 5 - 793 - 140,210 5 4,210 - 439 - 126,046 5 6,848 - 4,202 - 979,725 36 55,867 2 635,790 24 16,060 1 955,9849 37 2,357 -1,666,058 64 2,645,783 100 |
|||||||||||
1,793,215 2,557,633 |
||||||||||||
| $ | $ |
See accompanying notes to financial statements.
5
(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)
Rectron LTD. and Subsidiaries
Consolidated Statement of Comprehensive Income
For the Nine Months ended September 30, 2025 and 2024 (Expressed in Thousands of New Taiwan Dollar, except for Earnings per Common Share)
| 4000 Operating revenue(notes 6(o)and 7) 5000 Operating costs (notes 6(e) and 6(k)) Gross profit from operations Operating expenses (notes6(d) 、6(k)、6(p)、7 and12): 6100 Selling expenses 6200 Administrative expenses 6300 Research and development expenses Total operating expenses Net operating income Non-operating income and expenses(notes 6(q)and 7): 7010 Other income 7020 Other gains and losses 7050 Finance costs 7950 Total non-operating income and expenses Profit before tax Total tax expense (note 6(l)) Profit 300 Other comprehensive income (loss): 8310 Components of other comprehensive income that will not be reclassified to profit or loss: 8316 Unrealized gains (losses) from investments in equity instruments measured at fair value through other comprehensive income 8349 Income tax related to components of other comprehensive income that will not be reclassified to profit or loss Components of other comprehensive income that will not be reclassified to profit or loss 8360 Components of other comprehensive income (loss) that will be reclassified to profit or loss: Components of other comprehensive income that will be reclassified to profit or loss: 8361 Exchange differences on translation 8367 Unrealized gains (losses) from investments in debt instruments measured at fair value through other comprehensive income 8399 Income tax related to components of other comprehensive income that will be reclassified to profit or loss (note 6(p)) Total components of other comprehensive income that will be reclassified to profit or loss 8300 Other comprehensive income, net 8500 Comprehensive income Profit, attributable to: 8610 Profit, attributable to owners of parent Comprehensive income attributable to: 8710 Comprehensive income, attributable to owners of parent Earnings per common share (expressed in dollars) (note 6(n)) 9750 Basic earnings per share 9810 Diluted earnings per share |
For the three months ended | For the three months ended | For the three months ended | For the three months ended | For the three months ended | For the three months ended | For the three months ended | For the three months ended | For the three months ended | September 30 2024 % 201,799 100 129,525 64 72,274 36 16,300 8 31,043 15 1,807 1 49,150 24 23,124 12 5,365 3 (11,438) (6) (51) - (6,124) (3) 17,000 9 3,590 2 13,410 7 (105) - - - (105) - 4,622 2 2,670 1 - - 7,292 3 7,187 3 20,597 10 31,4101 7 20,597 10 0.08 0.08 |
For the Nine Months ended September 30 |
For the Nine Months ended September 30 |
For the Nine Months ended September 30 |
For the Nine Months ended September 30 |
||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ $ $ |
2025 $ 224,423 146,141 78,282 14,547 32,457 1,219 48,223 30,059 3,644 35,335 (44) 38,935 68,994 6,759 62,235 213 - 213 830 1,212 - 2,042 2,255 64,490 62,235 64,490 |
% 100 66 34 6 14 1 14 13 2 16 - 18 31 3 28 - - - - 1 - 1 1 29 |
2025 % 634,424 100 400,794 63 233,630 37 43,551 7 91,516 14 4,742 1 139,809 22 93,821 15 10,940 2 (16,753) (3) (136) - (5,949) (1) 87,872 14 21,796 3 66,076 11 (1,761) - - - (1,761) - (9,995) (2) 1,315 - - - (8,680) (2) (10,441) (2) 55,635 94 66,076 11 55,635 9 0.40 0.40 |
% | 2024 % 552,477 100 354,063 64 198,414 36 40,251 7 93,675 17 4,876 1 138,802 25 59,612 11 12,955 2 7,290 1 (223) - 20,022 3 79,634 14 16,150 2 63,484 12 1,607 - - - 1,607 - 13,474 2 618 - - - 14,092 2 15,699 2 79,183 14 63,484 12 79,183 14 0.38 0.38 |
|||||||||||||
| $ |
$ |
100 63 |
||||||||||||||||
| 34 | 37 | |||||||||||||||||
| 6 14 1 |
7 14 1 |
|||||||||||||||||
| 14 | 22 | |||||||||||||||||
| 13 | 15 | |||||||||||||||||
| 2 16 - |
2 (3) - |
|||||||||||||||||
| 18 |
(1) | |||||||||||||||||
31 3 |
14 3 |
|||||||||||||||||
| 28 | 11 | |||||||||||||||||
| - - |
- - |
|||||||||||||||||
| - | - | |||||||||||||||||
| - 1 - |
(2) - - |
|||||||||||||||||
| 1 | (2) | |||||||||||||||||
| 1 | (2) | |||||||||||||||||
| 29 | 94 |
|||||||||||||||||
| 28 | 11 9 |
|||||||||||||||||
| 29 | ||||||||||||||||||
| 0.38 1.38 |
||||||||||||||||||
See accompanying notes to financial statements.
6
(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)
Rectron LTD. and Subsidiaries
Consolidated Statement of Changes in Equity
For the Nine Months ended September 30, 2025 and 2024 (Expressed in Thousands of New Taiwan Dollar)
| Balance at January 1, 2024 Net income Other comprehensive income Total comprehensive income Appropriation and distribution of retained earnings: Legal reserve appropriated Special reserve appropriated Cash dividends of ordinary share Balance at September 30, 2024 Balance at January 1, 2025 Net income Other comprehensive income Total comprehensive income Appropriation and distribution of retained earnings: Legal reserve appropriated Special reserve appropriated Cash dividends of ordinary share Disposal of investments in equity instruments designated at fair value through other comprehensive income Balance at September 30, 2025 |
Attributable to owners ofparent | Attributable to owners ofparent | Attributable to owners ofparent | Attributable to owners ofparent | Attributable to owners ofparent | Total | Total equity | Total equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary share |
Capital surplus | Retained earnings | Total | Other equity | |||||||||||||||
| Legal reserve | Special reserve | Exchange differences on translation of foreign financial statements |
Unrealized gains (losses) from financial assets measured at fair value through other comprehensive income (4,039) - 2,225 2,225 - (1,814) (5,040) - (446) (446) (3,065) (8,551) |
||||||||||||||||
| $1,663,029 - - - - $ 1,663,029 $ 1,663,029 - - - - $ 1,663,029 |
9 - - - - 9 9 - - - - 9 |
51,988 - - - 8,666 - 60,654 60,655 - - - 12,614 - 73,269 |
60,074 - - - 27,069 - 87,143 87,143 - - - 16,153 - 103,296 |
87,640 63,484 - 63,484 (8,666) (27,069) (51,554) 63,834 126,496 66,076 - 66,070 (12,614) (16,153) (96,456) 3,065 70,414 |
(83,104) - 13,474 13,474 - (69,630) (98,256) - (9,995) (9,995) - (108,251) |
(87,143) - 15,699 15,699 - (71,444) (103,296) - 10,441 10,441 (3,065) (116,802) |
1,775,597 63,484 15,699 79,183 (51,554) 1,803,226 1,834,036 66,076 (10,441) 55,635 (96,456) 1,793,215 |
||||||||||||
$ |
|||||||||||||||||||
See accompanying notes to financial statements.
7
(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)
Rectron LTD. and Subsidiaries
Consolidated Statement of Cash Flows
For the Nine Months ended September 30, 2025 and 2024 (Expressed in Thousands of New Taiwan Dollars)
| Cash flows from(used in) operating activities: Profit before tax Adjustments: Adjustments to reconcile profit (loss): Depreciation expenses Amortization expenses Expected credit losses (gains) Interest expenses Interest income Dividend income Disposal of investment gains Net losses (gains) on financial assets at fair value through profit or loss Foreign exchange loss (gain) on financial assets Loss (gain) on disposal of property, plant and equipment Property, plant and equipment transferred to expenses Total adjustments to reconcile profit Changes in operating assets and liabilities: Changes in operating assets: Notes receivable Trade receivables Other receivables Inventories Prepayments Other current assets Total changes in operating assets Changes in operating liabilities: Current contract liabilities Trade payables Other payables Other current liabilities Net defined benefit liability Total changes in operating liabilities Total changes in operating assets and liabilities Total adjustments Cash inflow generated from operations Interest received Dividends received Interest paid Income taxes paid Net cash flows from operating activities Cash flows from (used in) investing activities: Proceeds from disposal of financial assets at fair value through other comprehensive income Acquisition of financial assets at amortized cost Acquisition of financial assets at fair value through profit or loss Proceeds from disposal of financial assets at fair value through profit or loss Acquisition of property, plant and equipment Proceeds from disposal of property, plant and equipment Increase in other non-current assets Increase in other current liabilities Net cash flows used in investing activities Cash flows from (used in) financing activities: Increase in short-term borrowings Decrease in short-term borrowings Repayment of lease principal Increase in other non-current liabilities Cash dividends paid Net cash flows used in financing activities Effect of exchange rate changes on cash and cash equivalents Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at the beginning of period Cash and cash equivalents at the end of period |
For | For | the Nine Months 30, |
ended September | ended September | ended September |
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| $ | 87,872 39,374 714 (2,786) 136 (10,775) (165) - (20,878) 2.868 (2) 1,247 9,733 336 (25,310) (3,966) (17,811) (5,285) (156) (52,192) 61 12,298 6,611 779 (81) 19,668 (32,524) 22,791 65,081 10,270 165 (136) (29,459) 45,921 10,925 (12,107) (298,275) 229,456 (197,500) 76 (363) 169,409 (98,379) - - (2,392) 139 (96,456) (98,709) (7,700) (158,867) 564,394 405,527 |
$ | 79,634 37,146 2,285 (2,279) 223 (12,213) (742) (37) (7,313) 174 - (2,071) |
|||
15,173 107 (41,403) (1,415) 12,044 (8,247) (463) |
||||||
$ |
$ |
|||||
| (39,377) | ||||||
| 1,153 50,971 2,965 265 (1,133) |
||||||
| 54,221 14,844 30,017 109,651 12,229 742 (243) (15,458)) |
||||||
106,894 3,259 - (24,341) 49,985 (20,372) - (1,309) 7,222 8,000 (20,000) (1,788) (4) (51,554) (65,346) |
||||||
| 21,297 70,067 561,703 631,770 |
See accompanying notes to financial statements.
8
(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)
Rectron Ltd. and Subsidiaries
Notes to Consolidated Financial Statements
September 30, 2025 and 2024
(Expressed in Thousands of New Taiwan Dollar, except for Earnings per Share Information and Unless Otherwise Specified)
1. Company history
Rectron Ltd. (the “Company”) was established and approved by the Ministry of Economic Affairs on January 23, 1976. The registered address is No. 71, Zhongshan Road, Tucheng District, New Taipei City. The Company was originally named "Rectron Precision Electronics Industry Co., Ltd." and changed its name to "Rectron Ltd." on June 29, 2000, as resolved by the shareholders' meeting and approved by the Ministry of Economic Affairs.
The Company and its subsidiaries (together referred to as the “Group”)main business operations include the manufacture and sale of various rectifiers, other semiconductor components, rental and sale of real estate, trading of wines, and manufacture and sale of medical equipment.
2. Approval date and procedures of the consolidated financial statements
The consolidated financial statements for the Nine Months ended September 30, 2025 and 2024were authorized for issuance by the board of directors on November 13, 2025.
3. New standards and interpretations not yet adopted
-
(a) The impact of the International Financial Reporting Standards (“IFRSs”) endorsed by the Financial Supervisory Commission, R.O.C. which have already been adopted.
-
The Group has initially adopted the (following) new amendments, which do not have a significant impact on its consolidated financial statements, from January 1, 2025
: -
Amendments to IAS21“Lack of Exchangeability”
-
Amendments to IFRS 9 and IFRS 7 “Amendments to the Classification and Measurement of Financial Instruments” regarding the application guidance requirements for Section 4.1 of IFRS 9 and the related disclosure requirements of IFRS 7.
-
-
(b) The impact of IFRS Accounting Standards endorsed by the FSC but not yet effective The Group’s anticipated adoption of the new amendments beginning on January 1, 2026, and concluded that their adoption will not have a material impact on the consolidated financial statements:
-
IFRS 17 “Insurance Contracts” and amendments to IFRS 17 “ Insurance Contracts”
-
Amendments to IFRS 9 and IFRS 7 “Amendments to the Classification and Measurement of Financial Instruments” regarding the application guidance requirements for Sections 3.1 and 3.3 of IFRS 9 and the related disclosure requirements of IFRS7.
-
Annual Improvements to IFRS Accounting Standards
-
(Continued)
9
–
Amendments to IFRS 9 and IFRS 7 “Contracts Referencing Nature-dependent Electricity”
- (c) The impact of IFRS Accounting Standards issued by IASB but not yet endorsed by the FSC The following new and amended standards, which may be relevant to the Group, have been issued by the International Accounting Standards Board (IASB), but have yet to be endorsed by the FSC:
| Standards or Interpretations IFRS 18 “Presentation and Disclosure in Financial Statements” |
Content of amendment The new standard introduces three categories of income and expenses, two income statement subtotals and one single note on management performance measures. The three amendments, combined with enhanced guidance on how to disaggregate information, set the stage for better and more consistent information for users, and will affect all the entities. A more structured income statement: under current standards, companies use different formats to present their results, making it difficult for investors to compare financial performance across companies. The new standard promotes a more structured income statement, introducing a newly defined ‘operating profit’ subtotal and a requirement for all income and expenses to be allocated between three new distinct categories based on a company’s main business activities. Management performance measures (MPMs): the new standard introduces a definition for management performance measures, and requires companies to explain in a single note to the financial statements why the measure provides useful information, how it is calculated and reconcile it to an amount determined under IFRS Accounting Standards. Greater disaggregation of information: the new standard includes enhanced guidance on how companies group information in the financial statements. This includes guidance on whether information is included in the primary financial statements or is further disaggregated in the notes. |
Effective date per IASB |
|---|---|---|
| January 1, 2027 |
The Group is evaluating the impact on its consolidated financial position and consolidated financial performance upon the initial adoption of the abovementioned standards or interpretations. The results thereof will be disclosed when the Group completes its evaluation.
The Group does not expect the following other new and amended standards, which have yet to be endorsed by the FSC, to have a significant impact on its consolidated financial statements:
-
Amendments to IFRS 10 and IAS 28 “Sale or Contribution of Assets Between an Investor and Its Associate or Joint Venture”
-
IFRS 19 “Subsidiaries without Public Accountability: Disclosures”
(Continued)
10
4. Summary of significant accounting policies
(1) Statement of compliance
These consolidated financial statements have been prepared in accordance with the preparation and guidelines of IAS 34 “Interim Financial Reporting” which are endorsed and issued into effect by FSC, and do not include all of the information required by the Regulations and International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations and SIC Interpretations endorsed and issued into effect by the FSC (hereinafter referred to IFRS endorsed by the FSC)for a complete set of the annual consolidated financial statements.
Except the following accounting policies mentioned below, the significant accounting policies adopted in the consolidated financial statements are the same as those in the consolidated financial statement for the year ended December 31, 2024. For the related information, please refer to note 4 of the consolidated financial statements for the year ended December 31, 2024.
(2) Basis of consolidation
(a) List of subsidiaries in the consolidated financial statements:
| Name of Name of investor subsidiary Principal activity The Company Rectron (China) Limited (Rectron China) Sales of rectifiers, etc. Electronic components The Company RECTRON ELECTRONIC ENTERPRISE S,INC (REEI) Sales of rectifiers, etc. Electronic components The Company CHU-TING ENTERPRISE CO., LTD. (Chu-Ting) Wholesale of tobacco and alcohol products and manufacturing and sales of medical equipment. Rectron (China) Limited Zhejiang Rectron Electronic Co.,LTD. (Zhejiang Rectron) Manufacturing and sales of rectifiers and other electronic components. |
Shareholding September 30, 2025 December 31, 2024 September 30, 2024 Description 100% 100% 100% Subsidiaries with direct ownership of voting rights exceeding 50% of the total shares issued. 100% 100% 100% Subsidiaries with direct ownership of voting rights exceeding 50% of the total shares issued.(Note) 100% 100% 100% Subsidiaries with direct ownership of voting rights exceeding 50% of the total shares issued. (Note) 100% 100% 100% Subsidiaries with indirect ownership of voting rights exceeding 50% of the total shares issued. |
|---|---|
Note : It is an insignificant subsidiary that the financial statements have not been reviewed.
(b) List of subsidiaries which are not included in the consolidated financial statements: None.
(3) Income tax
The income tax expenses have been prepared and disclosed in accordance with paragraph B12 of International Financial Reporting Standards 34, Interim Reporting.
Income tax expenses for the period are best estimated by multiplying pre-tax income for the interim reporting period using the effective annual tax rate as forecasted by the management. This should be recognized fully as tax expense for the current period (and allocated to current and deferred taxes based on its proportionate size).
For a change in tax rate that is substantively enacted in an interim period, the effect of the change should immediately be recognized in the interim period in which the change occurs.
Temporary differences between the carrying amounts of assets and liabilities for financial reporting
(Continued)
11
purposes and their respective tax bases shall be measured based on the tax rates that have been enacted or substantively enacted at the time of the asset or liability is recovered or settled, and be recognized directly in equity or other comprehensive income as tax expense.
(4) Employee benefits
The pension cost in the interim period was calculated and disclosed on a year-to-date basis by using the actuarially determined pension cost rate at the end of the prior fiscal year.
5. Significant accounting assumptions and judgments, and major sources of estimation uncertainty The preparation of the consolidated financial statements in conformity with the Regulations and IFRSs (in accordance with IAS 34“Interim Financial Reporting” and endorsed by the FSC) requires management to make judgments, estimates and assumptions that affect the application of the accounting policies and the reported amount of assets, liabilities, income and expenses. Actual results may differ from these estimates.
Except for the following, the preparation of the consolidated interim financial statements, estimates and underlying assumptions are reviewed on an ongoing basis which are in conformity with the consolidated financial statements for the year ended December 31, 2024. For related information, please refer to note 5of the consolidated financial statements for the year ended December 31, 2024.
6. Explanation of significant accounts
Except for the following disclosures, there were no material differences in the disclosures of significant accounts between the interim consolidated financial statements for the current period and the 2024 consolidated financial statements. Please refer to note6 to the 2024 annual consolidated financial statements.
- (a) Cash and cash equivalents
| Cash on hand and petty cash Cash in banks Time deposits Cash and cash equivalents in the consolidated statement of cash flows |
September 30, 2025 |
December 31, 2024 |
September 30, 2024 |
|---|---|---|---|
| $ 163 234,872 170,492 |
311 564,083 - |
144 590,481 41,145 |
|
| $ 405,527 | 564,394 |
631,770 |
Please refer to Note 6(r) for the fair value sensitivity analysis and interest rate risk of the financial assets and liabilities.
-
(b) Financial assets
-
Current financial assets at fair value through profit or loss
| September 30, 2025 Financial assets designation as measured at fair value through profit or loss Shares of stock of overseas $ 76,354 |
December 31, 2024 63,619 |
(Continued) September 30, 2024 153,374 |
|---|---|---|
| listed companies - NVDA Shares of stock of overseas listed companies - LMT 145,145 - Shares of stock of overseas listed companies - TESLA - 68,186 Assets mandatorily measured at fair value through profit or loss: Beneficiary certificates 773 770 Total $ 222,272 132,575 2. Non-current financial assets at fair value through other comprehensive income September 30, 2025 December 31, 2024 Debt investments at fair value through other comprehensive income Corporate bonds– Apple $ 24,341 25,602 Corporate bonds – AT&T 8,796 9,151 Corporate bonds–Pfizer 3,754 3,929 Equity investments at fair value through other comprehensive income Shares of stock of unlisted companies 4,499 17,185 Total $ 41,390 55,867 |
12 - - 812 16,186 September 30, 2024 26,635 9,680 4,266. 17,153 57,734 |
12 - - 812 16,186 September 30, 2024 26,635 9,680 4,266. 17,153 57,734 |
12 - - 812 16,186 September 30, 2024 26,635 9,680 4,266. 17,153 57,734 |
|---|---|---|---|
57,734 |
- (1) Debt investments at fair value through other comprehensive income
The Company consolidated investments in bonds measured at fair value through other comprehensive income in the financial statements as of September 30, 2025 December 31, 2024 and September 30, 2024. The effective interest rates range from 2.00% to 4.01%, and the maturity dates range from 2036 to 2045. The Company holds bond investments through the business model of collecting contractual cash flows and selling financial assets, and therefore reports them as financial assets measured at fair value through other comprehensive income.
-
(2) Equity investments at fair value through other comprehensive income
-
On 2025, the Company sold part of its shares in Sunny Bank that were classified as financial assets at fair value through other comprehensive income (FVOCI). The fair value at the time of disposal was $10,925 thousand, and the disposal gain amounted to $3,065 thousand. Accordingly, the accumulated disposal gain was reclassified from other equity to retained earnings.
(Continued)
13
-
(3) For credit risk (including the impairment of debt investments) and market risk; please refer to note 6(r).
-
(4) As of September 30, 2025, December 31, 2024 and September 30, 2024, the Group’s financial assets were not pledged as collateral.
-
(c) Financial assets measured at amortized cost
| Domestic and foreign time deposits Less: Loss allowance Total |
September 30, 2025 $ 12,107 - $ 12,107 |
|---|---|
$ $ |
The Group has assessed that these financial assets are held to maturity to collect cash flows, which consist solely of payments of principal and interest on principal amount outstanding. Therefore, these investments were classified as financial assets measured at amortized cost.
-
(1) As of September 30, 2025, the Group held both domestic and foreign time deposits, with the weighted-average interest rates of 2.180%, maturing in November 2025.
-
(2) For credit risk and market risk; please refer to note 6(r).
-
(3) As of September 30, 2025 the Group’s financial assets were not pledged as collateral.
(d) Trade receivables and notes receivable
| September 30, | September 30, | December 31, 2024 | September 30, | September 30, | |
|---|---|---|---|---|---|
| 2025 | 2024 | ||||
| Notes receivable from operating activities$ | 457 | 793 | 310 | ||
| Trade receivables | 186,934 | 163,249 | 157,053 | ||
| Trade receivables–Non-current | 48,227 | 48,227 | 48,227 | ||
| Less: Loss allowance | (66,855) | (71,266) | (71,224) | ||
| $ | 168,763 | 141,003 | $ | 134,366 |
The Group applies the simplified approach to provide for its expected credit losses, i.e. the use of lifetime expected loss provision for all receivables. To measure the expected credit losses, trade receivables have been grouped based on shared credit risk characteristics and the days past due, as well as incorporated forward looking information, including macroeconomic and relevant industry information. The loss allowance provision were determined as follows:
September 30, 2025
| Current Within 180 days past due. More than 180 days past due |
Gross carrying amount $ 142,714 26,238 66,666 $ 235,618 |
Weighted- average loss rate 0.05%~1% 0.05%~4.71% 0%~100% |
Loss allowance provision |
|---|---|---|---|
| 202 66,653 |
|||
| 66,855 |
(Continued)
14
| Current Within 180 days past due. More than 180 days past due |
December 31, 2024 | ||
|---|---|---|---|
| Gross carrying amount $ 112,799 27,236 72,236 $ 212,269 |
Weighted- average loss rate 0.05%~1.97% 0.05%~5.39% 0%~100% |
Loss allowance **provision ** |
|
| - - 71,266 |
|||
| 71,266 |
| Current Within 180 days past due. More than 180 days past due |
September 30, 2024 | September 30, 2024 | |
|---|---|---|---|
| Gross carrying amount $ 107,778 26,764 71,048 $ 205,590 |
Weighted- average loss rate 0.05%~1.98% 0.05%~9.64% 0%~100% |
Loss allowance provision |
|
| - 176 71,048 |
|||
| 71,224 |
The movements in the allowance for trade receivables and notes receivable were as follows:
| Balance at January 1 Impairment losses reversed Foreign exchange gains/(losses) Balance at September 30 |
For the Nine Months ended September 30, |
For the Nine Months ended September 30, |
For the Nine Months ended September 30, |
For the Nine Months ended September 30, |
|---|---|---|---|---|
| 2025 71,266 (2,786) (1,625) 66,855 |
2024 72,605 (2,279) 898 71,224 |
|||
| $ | ||||
| $ |
As of September 30, 2025, December 31, 2024 and September 30, 2024, the Group’s the aforementioned trade receivables and notes receivable were not pledged as collateral.
(Continued)
15
(e) Inventories
| entories | |||
|---|---|---|---|
| September 30, 2025 Raw materials and consumables 24,972 Work in progress 11,382 Finished goods 86,419 Merchandise 33,255 Goods and materials in transit 3,352 Subtotal 159,380 Less: Allowance for inventory market decline and obsolescence (15,523) 143,857 |
September 30, 2025 |
December 31, 2024 |
September 30, 2024 |
| 24,972 11,382 86,419 33,255 3,352 |
24,511 8,774 78,877 28,507 1,735 |
26,648 13,295 68,086 30,033 1,468 |
|
142,404 (16,358) |
139,530 (15,996) |
||
| 143,857 | 126,046 |
123,534 |
The details of inventory-related expenses recognized by the merged company for the periods July 1 to September 30, 2025 and 2024, as well as January 1 to September 30, 2025 and 2024, are as follows:
| Inventory that has been sold Write-down of inventories (Reversal of write-downs) The impact of actual production capacity being lower than normal capacity. Total |
For the three months ended September 30, 2025 2025 $ 142,470 $ 127,971 1,257 (929) 922 761 $ 144,649 127,803 |
For the three months ended September 30, 2025 2025 $ 142,470 $ 127,971 1,257 (929) 922 761 $ 144,649 127,803 |
For the three months ended September 30, 2025 2025 $ 142,470 $ 127,971 1,257 (929) 922 761 $ 144,649 127,803 |
For the Nine Months ended September 30, |
For the Nine Months ended September 30, |
For the Nine Months ended September 30, |
For the Nine Months ended September 30, |
|
|---|---|---|---|---|---|---|---|---|
| 2024 394,410 - 1,541 |
2024 | |||||||
| $ 142,470 1,257 922 |
343,915 (427) 5,259 |
|||||||
| $ 144,649 | 127,803 | 395,951 |
248,747 |
(1) Reversal gains were generated from inventory depletion during the periods from the three months and the Nine Months ended September 30, 2025 and 2024 respectively.
(2)As of September 30, 2025, December 31, 2024 and September 30, 2024, the Group’s the aforementioned trade receivables and notes receivable were not pledged as collateral.
(Continued)
16
(f) Property, plant and equipment
The cost and accumulated depreciation of the property, plant and equipment of the Group for the Nine Months ended September 30, 2025 and 2024 were as follows:
| Cost: Balance at January 1, 2025 Additions Reclassification Reduction Effect of movement in exchange rates Balance at September 30, 2025 Balance at January 1, 2024 Additions Reclassification Effect of movement in exchange rates Balance at September 30, 2024 Accumulated depreciation: Balance at January 1, 2025 Depreciation Reduction Effect of movement in exchange rates Balance as of September 30, 2025 Balance as of January 1, 2024 Depreciation Effect of movement in exchange rates Balance at September 30, 2024 Carrying value: Balance atJanuary1, 2025 Balance at September 30, 2025 Balance at January1, 2024 Balance at September 30, 2024 |
Land | Buildings and structures 254,947 8,757 156,352 - (16,117) 403,939 248,881 304 - 6,511 255,696 149,482 10,950 - (4,984) 155,448 135,743 7,679 3,956 147,378 105,465 248,491 113,138 108,318 |
Machinery and equipment |
Office equipment 59,827 714 2,092 (11,555) (1,377) 49,701 56,394 926 1,806 649 59,775 54,370 1,777 (11,550) (1,362) 43,235 50,817 2,167 607 53,591 5,457 6,466 5,577 6,184 |
C | onstruction in progress 221,330 4,459 (176,273) (386) (2,572) 46,558 13,337 196,936 (5,818) 2,163 206,618 - - - - - - - - - 221,330 46,558 13,337 206,618 |
Total 1,415,838 18,255 (12,366) (284,285) (53,215) 1,084,227 1,177,102 200,457 (2,071) 25,693 1,401,181 780,048 29,603 (262,083) (35,611) 511,957 718,515 27,516 18,667 764,698 635,790 572,270 458,587 636,483 |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ $ $ $ $ $ $ $ $ $ $ $ |
181,394 - - - - |
698,340 4,325 5,463 (272,344) (33,149) 402,635 677,096 2,291 1,941 16,370 697,698 531,955 16,876 (250,533) (29,265) 313,274 531,955 17,670 14,104 563,729 122,114 89,361 145,141 133,969 |
||||||||||
181,394 |
||||||||||||
181,394 - - - |
||||||||||||
181,394 |
||||||||||||
- - - - |
||||||||||||
- |
||||||||||||
- - - |
||||||||||||
- |
||||||||||||
181,394 |
||||||||||||
181,394 |
||||||||||||
181,394 |
||||||||||||
181,394 |
As of September 30, 2025, December 31, 2024 and September 30, 2024, the Property, plant and equipment of the Group had been pledged as collateral for long-term borrowings; please refer to note 8.
For the details regarding the subsidiary Zhejiang Rectron housing and construction relocation agreement with Jiashan Economic Development Zone Asset Management Co., Ltd., please refer to Note 9(b).
(g) Right-of-use assets
The Group leases many assets including land and buildings, vehicles, and other equipment.
Information about leases for which the Group is a lessee is presented below:
| Cost: Balance at January 1, 2025 Reclassification Effect of movement in exchange rates Balance at September 30, 2025 |
Land $ 10,276 (11,119) (107) $ 21,288 |
Buildings 13,716 - (986) 12,730 |
Machinery and equipment 2,514 - - 2,514 |
Other equipment 343 - - 343 |
Total |
|---|---|---|---|---|---|
| 26,849 11.119 (1,093) |
|||||
36,875 |
(Continued)
17
| Land Balance at January 1, 2024 $ 9,906 Additions Effect of movement in exchange rates419 Balance at September 30, 2024 $ 10,325 Accumulated depreciation and impairment losses: Balance at January 1, 2025 $ 1,891 Depreciation for the year 422 Effect of movement in exchange rates (89) Balance at September 30, 2025 $ 2,224 Balance at January 1, 2024 $ 1,250 Depreciation for the year 233 Effect of movement in exchange rates 67 Balance at September 30, 2024 $ 1,820 Carrying amount: Balance at January 1, 2025 $ 8,385 Balance at September 30, 2025 $ 19,064 Balance at January 1, 2024 $ 8,386 Balance at September 30, 2024 $ 8,505 |
Buildings 12,826 414 13,240 8,474 1,707 (648) 9,533 5,724 1,723 162 7,609 5,242 3,197 7,102 5,631 |
Machinery and equipment - 2,514 - 2,514 280 628 - 908 - 70 - 70 2,234 1,606 - 2,444 |
Machinery and equipment - 2,514 - 2,514 280 628 - 908 - 70 - 70 2,234 1,606 - 2,444 |
Machinery and equipment - 2,514 - 2,514 280 628 - 908 - 70 - 70 2,234 1,606 - 2,444 |
Other equipment 343 - 343 144 52 - 196 72 54 - 126 199 147 271 217 |
Total | ||
|---|---|---|---|---|---|---|---|---|
| 23,075 2,514 833 |
||||||||
| 26,422 | ||||||||
| 10,789 2,809 (737) |
||||||||
| 12,861 | ||||||||
| 7,316 2,080 229 |
||||||||
| 9,625 | ||||||||
| 16,060 24,014 15,459 16,797 |
||||||||
-
In 2025, the subsidiary Zhejiang Rectron acquired a parcel of land located in Huimin Sub-district, Jiashan County, Zhejiang Province, with a total area of 3,031 square meters. The land use right, designated for the Company’s plant and office purposes, was recognized at an original cost of $11,119 thousand (RMB 2,694 thousand). The land use right has a term of 50 years and is amortized on a straight-line basis over the actual period of use.
-
For the details regarding the subsidiary Zhejiang Rectron right-of-use assets land relocation agreement with Jiashan Economic Development Zone Asset Management Co., Ltd., please refer to Note 9(b).
(h) Investment property
| Cost: Balance at January 1, 2025 Reduction (15,130(Effect of movement in exchange rates Balance at September 30, 2025 |
Land and improvements $ 663,510 - $ 663,510 |
Buildings 377,011 (15,130) (4,927) 356,954 |
Total |
|---|---|---|---|
1,040,521 (15,130) (4,927) |
|||
1,020,464 |
(Continued)
18
| Balance at January 1, 2024 Effect of movement in exchange rates Balance at September 30, 2024 Accumulated depreciation and impairment losses: Balance at January 1, 2025 Depreciation for the year Reduction Effect of movement in exchange rates Balance at September 30, 2025 Balance at January 1, 2024 Depreciation for the year Effect of movement in exchange rates Balance at September 30, 2024 Carrying amount: Balance at January 1, 2025 Balance at September 30, 2025 Balance at January 1, 2024 Balance at September 30, 2024 |
Land and improvements $ 663,510 - $ 663,510 $ - - - $ - $ - - - $- $ 663,510 $ 663,510 $ 663,510 $ 663,510 |
Buildings 373,879 3,540 377,419 84,537 6,962 (9,306) (1,959) 80,234 73,500 7,550 1,099 82,149 292,474 276,720 300,379 295,270 |
Total | ||
|---|---|---|---|---|---|
| 1,037,389 3,540 |
|||||
| 1,040,929 | |||||
| 84,537 6,962 (9,306) (1,959) |
|||||
| 80,234 | |||||
| 73,500 7,550 1,099 |
|||||
| 82,149 | |||||
| 955,984 | |||||
940,230 |
|||||
963,889 |
|||||
958,780 |
-
Investment properties are self-owned assets held by the Consolidated Companies. The lease term for investment properties ranges from 1 to 6 years, and it is non-cancellable. Due to the need for organic renewal and industrial transformation and upgrading in the Jiashan Economic and Technological Development Industrial Park, where the subsidiary Zhejiang Rectron is located, Zhejiang Rectron agreed to vacate the premises with Jiashan Economic Development Zone Asset Management Co., Ltd. on September 22, 2024. Therefore, the lease contract was terminated at the end of August 2024. Please refer to Note 9(b) for details.
-
Due to the restriction in the law at that time, private entities were not allowed to acquire agricultural land. Therefore, the Consolidated Companies appointed Mr. Lin Wen-Teng, one of the directors, to register the real estate investment under his personal name. To ensure the preservation of the Consolidated Companies' assets, the property has been pledged back to the Consolidated Companies.
-
The fair value of investment property was not significantly different from those disclosed in Note 6(g) of the annual consolidated financial statements for the year ended December 31, 2024.
-
As of September 30, 2025, December 31, 2024 and September 30, 2024, the Property, plant and equipment of the Group had been pledged as collateral for long-term borrowings; please refer to note 8.
(Continued)
19
(h) Short-term borrowings
| m borrowings | |||
|---|---|---|---|
| Secured bank loans Unused short-term credit lines Range of interest rates |
September 30, 2025 | December 31, 2024 | September 30, 2024 |
| $ - | - |
3,000 | |
| $ 340,000 | 420,000 |
417,000 | |
| - | 1.90%~2.01% | 1.90%~2.01% |
For the collateral for short-term borrowings, please refer to note 8.
(i)Operating Lease
There were no significant changes in operating lease for the Nine Months ended September 30, 2025 and 2024. Please refer to Note 6(i) of the consolidated financial statements for the year ended December31, 2024 and 2023 for other related information.
(j)Provisions
1. Defined benefit plans
Management believes that there was no material volatility of the market, no material reimbursement and settlement or no other material onetime events since prior fiscal year. As a result, thepensioncostintheaccompanyinginterimperiodwasmeasuredanddisclosedaccording to the actuarial report as of December 31, 2024and 2022.
The expenses recognized in profit or loss for the Group are as follows:
| Operating cost Selling expenses Total |
For the Three months Ended September 30 For the Nine Months Ended September 30 |
For the Three months Ended September 30 For the Nine Months Ended September 30 |
For the Three months Ended September 30 For the Nine Months Ended September 30 |
For the Three months Ended September 30 For the Nine Months Ended September 30 |
|---|---|---|---|---|
| 2025 | 2024 1 5 11 |
2025 | 2024 6 15 21 |
|
| - - - |
- - - |
2. Defined contribution plans
The Group’s employee benefit retirement expenses respectively.
| Operating cost Selling expenses Administration expenses Research and development expenses Total |
For the Three months Ended September 30 |
For the Nine Months Ended September 30 |
For the Nine Months Ended September 30 |
|---|---|---|---|
| 2025 2024 |
2025 | 2024 371 144 609 11 1,135 |
|
| $ 117 118 68 51 189 208 - - |
352 200 612 - 1,164 |
||
| $ 374 377 |
(Continued)
20
- The detailed breakdown of retirement benefit expenses recognized by foreign subsidiaries in accordance with relevant local regulations is as follows:
| Administration expenses | For the Three months Ended September 30 |
For the Nine Months Ended September 30 |
|---|---|---|
| 2025 2024 |
2025 2024 2,685 2,635 |
|
| $ 869 823 |
(k) Income tax
- The components of income tax for the Nine Months ended September 30, 2025 and 2024 were as follows:
| were as follows: | ||||
|---|---|---|---|---|
| Current tax expenses Prior years income tax adjustment |
For the three months ended September 30 2025 2024 $ 6,759 3,590 - - $6,759 3,590 |
For the Nine Months ended September 30 |
||
| 2025 $ 6,759 - $6,759 |
2025 22,228 (432) 21,796 |
2024 | ||
| 3,590 - 3,590 |
16,050 100 |
|||
| 16,150 |
- (1) Company’s income tax return for the year 2023 as been examined by the tax authorities.
(2)The domestic subsidiaries of the Company have filed and settled their corporate income tax returns with the tax authorities up to the fiscal year 2023 as approved.
(l)Capital and other equity
Except for the following disclosure, there was no significant change in capital and other equity for the periods from January 1 to September 30, 2025 and 2024. For the related information, please refer to note 6(l) to the consolidated financial statements for the year ended December 31, 2024.
- Retained earnings
If the Company has surplus in the annual final accounts, it shall pay taxes and donations in accordance with the law, offset cumulative losses, and then appropriate 10% as statutory surplus reserve. However, when the statutory surplus reserve has reached the Company's paid-in capital, no further appropriation is required. The remaining surplus shall be appropriated or reversed as required by laws and regulations, or transferred to the special surplus reserve. If there is still surplus, together with undistributed surplus at the beginning of the period, it will be classified as distributable surplus. The Board of Directors shall propose a surplus distribution plan for approval by the shareholders' meeting, and distribute dividends to the shareholders.
Taking into account financial, operational, and business factors, the Company may distribute dividends to shareholders, which shall not be less than 10% of the distributable surplus for the current fiscal year. However, if the accumulated distributable surplus is less than 3% of the paidin capital, no distribution shall be made. Dividends may be distributed in the form of cash dividends or stock dividends. Cash dividends shall be given priority in the distribution of earnings, but stock dividends may also be distributed. The proportion of cash dividends shall not be less than 10% of the total dividend amount.
For the distribution of dividends to shareholders in the form of cash, the Board of Directors is authorized to carry out such distribution with the approval of two-thirds or more of the attending directors and a majority of the attending directors, and to report it to the shareholders' meeting.
(Continued)
21
(i) Legal reserve
When a company incurs profit, the shareholders shall decide on the distribution of the statutory earnings reserve either by issuing new shares or by paying cash of up to 25% of the actual share capital.
(ii) Special reserve
The Company chose to apply the exemption under IFRS 1 at its initial adoption of IFRSs. Any unrealized revaluation surplus, accumulated translation adjustment, and increasing amount incurred from adopting the fair value as cost for the assets classified as investment property at the transition date. According to the Financial Supervisory Commission's Order No. 1010012865 issued on April 6, 2012, an equal amount shall be appropriated to the special surplus reserve. When using, disposing of, or reclassifying related assets, a proportionate reversal of the originally appropriated special surplus reserve may be distributed as earnings.
According to the regulations of the Financial Supervisory Commission, when the Company distributes distributable earnings, the difference between the net amount of reductions in other shareholders' equity items recorded in the current year and the balance of the special surplus reserve mentioned above shall be considered. When distributing earnings for the fiscal year 2024, the Company will allocate the current year's income and the undistributed earnings from previous periods to the special surplus reserve. When distributing earnings for the fiscal year 2025, the Company will allocate the current year's after-tax net profit, along with items other than the current year's after-tax net profit, to the undistributed earnings and the special surplus reserve from previous periods. The Company is not allowed to distribute the amounts related to reductions in other shareholders' equity from previous periods, except for the allocation to the special surplus reserve. In the event of reversals in the amounts of reductions in other shareholders' equity in the future, earnings may be distributed based on the reversed portion. As of September 30, 2025, December 31, 2024, and September 30, 2024, the balance of the special surplus reserve is $103,296 thousand, $87,143 thousand, and $87,143 thousand, respectively.
(iii) Earnings distribution
The amounts of cash dividends and share dividends for the 2024 and 2023 earnings distribution had been approved, the board meeting held on March 11, 2025 and March 15, 2024; while the earnings distribution for 2024 and 2023 had been approved during the shareholders’ meeting on May 29, 2025 and June 26, 2024 as follows:
| Cash dividends distributed to ordinary shareholders |
2024 Amount per share Total amount $0.58 96,456 |
2024 Amount per share Total amount $0.58 96,456 |
2023 |
|---|---|---|---|
| Amount per share $0.58 |
Amount per share Total amount 0.31 51,554 |
||
| 96,456 |
(Continued)
22
(iv) OCI accumulated in reserves
| Balance at January 1, 2025 Exchange differences on foreign operations Unrealized gains (losses) from financial assets measured at fair value through other comprehensive income ((Disposal of investments in equity instruments designated at fair value through other comprehensive income Balance at September 30, 2025 Balance at January 1, 2024 Exchange differences on foreign operations Unrealized gains (losses) from financial assets measured at fair value through other comprehensive income Balance at September 30, 2024 |
Exchange differences on translation of foreign financial statements $ (98,256) (9,995) - $ (108,251) $ (83,104) 13,474 - $ (69,630) |
Unrealized gains (losses) from financial assets measured at fair value through other comprehensive income Total (5,040) (103,296) - (9,995) (446) (446) (3,065) (3,065) |
|---|---|---|
| (8,551) (116,802) |
||
| (4,039) (87,143) - 13,474 2,225 2,225) |
||
| (1,814) (71,444) |
(m) Earnings per share
For the Nine Months ended September 30, 2025 and 2024, the Company’s earnings per share were calculated as follows:
1. Basic earnings per share
(i) Profit attributable to ordinary shareholders of the Company
| Profit/(loss) of the Company for the (ii) Weighted-average number Weighted-average number of ordinary shares(thousand shares) Earnings per share |
For the three months ended September 30 2025 2024 year $ 62,235 13,410 of ordinary shares For the three months ended September 30 2025 2024 $ 166,303 166,303 0.38 0.08 |
For the three months ended September 30 |
For the three months ended September 30 |
For the Nine Months ended September 30 2025 2024 66,076 63,484 For the Nine Months ended September 30 |
For the Nine Months ended September 30 2025 2024 66,076 63,484 For the Nine Months ended September 30 |
|
|---|---|---|---|---|---|---|
| 2024 | ||||||
| 13,410 | ||||||
| 2025 166,303 0.4 |
2024 | |||||
| 166,303 | ||||||
| 0.38 |
2. Diluted earnings per share
The diluted earnings per share of the Group for the fiscal year 2025 and the period from January 1, 2024, to September 30, 2024, are calculated based on the net income attributable to the equity holders of the Company and the adjusted weighted average number of ordinary shares outstanding, considering the dilutive effects of all potential ordinary shares. The calculations are as follows:
(Continued)
23
(i) Profit attributable to ordinary shareholders of the Company
| For the three months ended September 30 2025 2024 Profit/(loss) attributable to ordinary shareholders of the Company (basic) $62,235 13,410 (ii) Weighted-average number of ordinary shares For the three months ended September 30 2025 2024 Weighted-average number of ordinary shares (thousand shares) (basic) $166,303 166,303 Effect of employee share bonus 52 48 Weighted-average number of ordinary shares (thousand shares) (diluted) 166,355 166,349 Earnings per share 0.38 0.08 |
For the three months ended September 30 2025 2024 Profit/(loss) attributable to ordinary shareholders of the Company (basic) $62,235 13,410 (ii) Weighted-average number of ordinary shares For the three months ended September 30 2025 2024 Weighted-average number of ordinary shares (thousand shares) (basic) $166,303 166,303 Effect of employee share bonus 52 48 Weighted-average number of ordinary shares (thousand shares) (diluted) 166,355 166,349 Earnings per share 0.38 0.08 |
For the three months ended September 30 2025 2024 Profit/(loss) attributable to ordinary shareholders of the Company (basic) $62,235 13,410 (ii) Weighted-average number of ordinary shares For the three months ended September 30 2025 2024 Weighted-average number of ordinary shares (thousand shares) (basic) $166,303 166,303 Effect of employee share bonus 52 48 Weighted-average number of ordinary shares (thousand shares) (diluted) 166,355 166,349 Earnings per share 0.38 0.08 |
For the Nine Months ended September 30 |
For the Nine Months ended September 30 |
|---|---|---|---|---|
| 2025 2024 66,076 63,484 For the Nine Months ended September 30 2025 2024 166,303 166,303 72 62 166,379 166,365 0.40 0.38 |
2024 63,484 |
|||
| 2025 $166,303 52 166,355 0.38 |
2025 166,303 72 166,379 0.40 |
|||
| 166,303 48 166,349 0.08 |
- (n) Revenue from contracts with customers
i. Disaggregation of revenue
For the three months ended September 30, 2025
| Electronics Division Primary geographical markets Asia $ 192,248 America 20,965 Europe 3,464 Others 138 $ 216,815 Major products/services lines Electronic Components Sales $216,815 Rental Income - Medical Equipment Sales - Wine Trading - $216,815 |
Property Management Division 5,172 - - - 5,172 - 5,172 - - 5,172 |
Medical Equipment Division 1,810 - - 1,810 - - 1,810 - 1810 |
Wine Trading Department 626 - - - |
Total |
|---|---|---|---|---|
| 199,856 20,965 3,464 138 |
||||
| 626 | 224,423 | |||
| - - - 626 626 |
216,815 5,172 1,810 626 |
|||
| 224,423 |
(Continued)
24
For the three months ended September 30, 2024
| Electronics Division Property Management Division Medical Equipment Division Wine Trading Department Primary geographical markets Asia $ 169,666 6,016 1,972 846 America 21,102 - - - Europe 1,873 - - - Others 324 - - - $ 192,965 6,016 1,972 846 Major products/services lines Electronic Components Sales $ 192,965 - - - Rental Income - 6,016 - - Medical Equipment Sales - - 1,972 - Wine Trading - - - 846 $ 192,965 6,016 1,972 846 For the Nine Months ended September 30, 2025 Electronics Division Property Management Division Medical Equipment Division Wine Trading Department Primary geographical markets Asia $ 526,560 16,509 6,754 3,354 America 72,487 - - - Europe 8,170 - - - Others 590 - - - $ 607,807 16,509 6,754 3,354 Major products/services lines Electronic Components Sales $ 607,807 - - - Rental Income - 16,509 - - Medical Equipment Sales - - 6,754 - Wine Trading - - - 3,354 $ 607,807 16,509 6,754 3,354 |
Electronics Division Property Management Division Medical Equipment Division Wine Trading Department Primary geographical markets Asia $ 169,666 6,016 1,972 846 America 21,102 - - - Europe 1,873 - - - Others 324 - - - $ 192,965 6,016 1,972 846 Major products/services lines Electronic Components Sales $ 192,965 - - - Rental Income - 6,016 - - Medical Equipment Sales - - 1,972 - Wine Trading - - - 846 $ 192,965 6,016 1,972 846 For the Nine Months ended September 30, 2025 Electronics Division Property Management Division Medical Equipment Division Wine Trading Department Primary geographical markets Asia $ 526,560 16,509 6,754 3,354 America 72,487 - - - Europe 8,170 - - - Others 590 - - - $ 607,807 16,509 6,754 3,354 Major products/services lines Electronic Components Sales $ 607,807 - - - Rental Income - 16,509 - - Medical Equipment Sales - - 6,754 - Wine Trading - - - 3,354 $ 607,807 16,509 6,754 3,354 |
Electronics Division Property Management Division Medical Equipment Division Wine Trading Department Primary geographical markets Asia $ 169,666 6,016 1,972 846 America 21,102 - - - Europe 1,873 - - - Others 324 - - - $ 192,965 6,016 1,972 846 Major products/services lines Electronic Components Sales $ 192,965 - - - Rental Income - 6,016 - - Medical Equipment Sales - - 1,972 - Wine Trading - - - 846 $ 192,965 6,016 1,972 846 For the Nine Months ended September 30, 2025 Electronics Division Property Management Division Medical Equipment Division Wine Trading Department Primary geographical markets Asia $ 526,560 16,509 6,754 3,354 America 72,487 - - - Europe 8,170 - - - Others 590 - - - $ 607,807 16,509 6,754 3,354 Major products/services lines Electronic Components Sales $ 607,807 - - - Rental Income - 16,509 - - Medical Equipment Sales - - 6,754 - Wine Trading - - - 3,354 $ 607,807 16,509 6,754 3,354 |
Electronics Division Property Management Division Medical Equipment Division Wine Trading Department Primary geographical markets Asia $ 169,666 6,016 1,972 846 America 21,102 - - - Europe 1,873 - - - Others 324 - - - $ 192,965 6,016 1,972 846 Major products/services lines Electronic Components Sales $ 192,965 - - - Rental Income - 6,016 - - Medical Equipment Sales - - 1,972 - Wine Trading - - - 846 $ 192,965 6,016 1,972 846 For the Nine Months ended September 30, 2025 Electronics Division Property Management Division Medical Equipment Division Wine Trading Department Primary geographical markets Asia $ 526,560 16,509 6,754 3,354 America 72,487 - - - Europe 8,170 - - - Others 590 - - - $ 607,807 16,509 6,754 3,354 Major products/services lines Electronic Components Sales $ 607,807 - - - Rental Income - 16,509 - - Medical Equipment Sales - - 6,754 - Wine Trading - - - 3,354 $ 607,807 16,509 6,754 3,354 |
Total |
|---|---|---|---|---|
| 178,500 21,102 1,873 324 |
||||
| 201,799 | ||||
| 192,965 6,016 1,972 846 |
||||
| 201,799 | ||||
| Property Management Division 16,509 - - - 16,509 - 16,509 - - 16,509 |
Medical Equipment Division 6,754 - - - 6,754 - - 6,754 - 6,754 |
Wine Trading Department 3,354 - - - |
Total | |
| 553,177 72,487 8,170 590 |
||||
| 3,354 | 634,424 | |||
| - - - 3,354 3,354 |
607,807 16,509 6,754 3,354 |
|||
| 634,424 |
(Continued)
25
For the Nine Months ended September 30, 2024
| Electronics Division Primary geographical markets Asia $ 459,876 America 60,650 Europe 4,567 Others 958 $ 526,051 Major products/services lines Electronic Components Sales $ 526,051 Rental Income - Medical Equipment Sales - Wine Trading - $ 526,051 |
Property Management Division 17,139 - - - 17,139 - 17,139 - - 17,139 |
Medical Equipment Division 6,768 - - - 6,768 - - 6,768 - 12,736 |
Wine Trading Department 2,519 - - - 2,519 - - - 2,519 2,519 |
Total |
|---|---|---|---|---|
| 486,302 60,650 4,567 958 |
||||
| 552,477 | ||||
| 526,051 17,139 6,768 2,519 |
||||
| 552,477 |
ii. Contract balances
| Contract balances | ||||||
|---|---|---|---|---|---|---|
| Trade receivables and notes receivable Less: allowance for impairment Contract liabilities |
September 30, 2025 $ 187,391 (18,628) $ 168,763 $ 99 |
December 31, 2024 164,042 (23,039) |
September 30, 2024 157,363 (22,997) |
|||
| $ | 141,003 | 134,366 | ||||
| $ | 38 | 1,221 |
For details on trade receivables and allowance for impairment, please refer to note 6(d).
(o) Remunerations to employees, directors and supervisors
According to the Company’s Articles of Incorporation, if the Company has earnings for the year (earnings being defined as profit before tax and before deduction of employees’ and directors’ remuneration), no less than 1% of such earnings shall be allocated as employees’ remuneration (of which not less than 30% shall be distributed to rank-and-file employees) and no more than 2% shall be allocated as directors’ remuneration; however, if the Company still has accumulated losses, the amount required to be reserved for making up such losses shall be retained in advance. The recipients of the aforementioned employees’ remuneration, whether in the form of shares or cash, may include employees of the Company’s subsidiaries who meet certain criteria.
(Continued)
26
For the three months and the Nine Months ended September 30, 2025 and 2024, remuneration of employees of $600 thousand, $190 thousand, $900 thousand, and $840 thousand, respectively, and remuneration of directors of $400 thousand, $150 thousand, $600 thousand, and $900 thousand, respectively, were estimated on the basis of the Company’s net profit before tax, excluding the remuneration of employees and directors of each period, multiplied by the percentage of remuneration of employees and directors as specified in the Company’s articles of incorporation. Such amounts were recognized as operating expenses for the Nine Months ended September 30, 2025 and 2024, Management is expecting that the differences, if any, between the actual distributed amounts and estimated amounts will be treated as changes in accounting estimates and will be charged to profit or loss. The number of shares to be distributed was calculated based on the closing price of the Company’s ordinary shares, one day prior to Board of Directors meeting.
For 2024, the amounts of employees’ and directors’ remuneration as resolved by the Board of Directors were consistent with the amounts accrued in the parent company only financial statements. For 2023, the amount of employees’ remuneration as resolved by the Board of Directors was consistent with the amount accrued in the parent company only financial statements; however, the amount of directors’ remuneration as resolved by the Board of Directors differed from the accrued amount in the parent company only financial statements by $600 thousand. The difference was mainly due to an accounting estimate discrepancy of the Company and was recognized in profit or loss for 2024. Relevant information can be found on the Market Observation Post System (MOPS).
- (p) Non-operating income and expenses
1. Other income
| Interest income Dividend income |
For the three months ended September 30 2025 2024 $ 3,529 4,814 115 551 $ 3,644 5,365 |
For the Nine Months ended September 30 |
For the Nine Months ended September 30 |
|---|---|---|---|
| 2025 $ 3,529 115 $ 3,644 |
2025 10,775 165 **10,940 ** |
2024 | |
12,213 742 |
|||
12,955 |
- Other gains and losses
| er gains and losses | er gains and losses | |||
|---|---|---|---|---|
| For the three months ended September 30 For the Nine Months ended September 30 2025 2024 2025 2024 Foreign exchange gains (losses) $ 255 (12,170) (38,870)) (156) Gains (losses) on financial assets at fair value through profit or loss 34,898 667 20,878 7,313 Gains on disposals of property, land and equipment 2 - 2 - Disposal of investment losses - - - 37 Others 180 65 237 96 $ 35,335 (11,438) (16,753) 7,290 ance costs For the three months ended September 30 For the Nine Months ended September 30 2025 2024 2025 2024 Interest expense $(44) (51) (136) (223) |
For the Nine Months ended September 30 |
|||
| 2024 | ||||
| (156) 7,313 - 37 96 |
||||
| 7,290 | ||||
| 2025 **(136) ** |
2024 | |||
(223) |
- Finance costs
(Continued)
(q) Financial instruments
1. Credit risk
(i) Credit risk exposure
The carrying amount of financial assets and contract assets represents the maximum amount exposed to credit risk.
(ii) Concentration of credit risk
The Group has a broad customer base and does not engage in significant transactions with any single customer. Additionally, its sales are geographically diversified. Therefore, there is no significant concentration of credit risk.
(iii) Receivables and debt securities
For credit risk exposure of trade receivables and notes receivable, please refer to note 6(c). Other financial assets at amortized cost include other receivables. All of these financial assets are considered to have low risk, and thus, the impairment provision recognized during the period was limited to 12-month expected credit losses. The fixed deposits held by the group are transacted with and settled by financial institutions that have investment-grade ratings or above. Therefore, they are considered to have low risk.
The loss allowances were determined as follows:
| Balance at January 1, 2025 Balance at September 30, 2025 Balance at January 1, 2024 Balance at September 30, 2024 |
Other receivables |
|---|---|
| $ 36,992 | |
| $ 36,992 | |
| $ 36,992 | |
| $ 36,992 |
(Continued)
28
2. Liquidity risk
The following table shows the contractual maturities of financial liabilities, including estimated interest payments and excluding the impact of netting agreements.
| September 30, 2025 Non-derivative financial liabilities Non-interest bearing liabilities Lease liabilities(include non- current) December 31, 2024 Non-derivative financial liabilities Non-interest bearing liabilities Lease liabilities(include non- current) September 30, 2024 Non-derivative financial liabilities Floating rate instruments Non-interest bearing liabilities Lease liabilities(include non- current) |
Carrying amount Contractual cash flows Within 6 months |
6-12 m | onths | 1 | -2 years 2-5 years |
Over 5 years |
|---|---|---|---|---|---|---|
| $ 190,537 190,537 190,500 5,156 5,362 1,666 |
37 1,676 |
- - 2,020 |
- - - |
|||
$ 195,693 195,889 192,166 |
1,713 |
2,020 - |
||||
| $ 350,873 350,873 350,836 7,900 8,519 1,729 |
37 1,760 1,760 |
- - - 3,334 1,336 - 3,334 1,336 |
- - |
|||
$ 358,773 359,032 352,565 |
||||||
$ 3,000 3,010 3,010 342,231 342,231 342,231 8,503 8,789 1,686 |
- - 1,700 1,700 |
- - - - 3,445 1,958 - 3,445 1,958 |
- - - |
|||
$ 353,734 354,030 346,927 |
The Group does not expect the cash flows included in the maturity analysis to occur significantly earlier or at significantly different amounts.
-
Market risk
-
(i) Currency risk
The Group’s significant exposure to foreign currency risk was as follows:
| Financial assets Monetary items USD : NTD USD : CNY USD : HKD Non-monetary items USD Financial liabilities Monetary items USD : NTD USD : CNY |
September 30, 2025 | December 31, 2024 |
|---|---|---|
| Foreign currency Exchange rate NTD $ 12,199 30.445 371,399 1,427 7.780 43,445 399 7.780 12,107 1,212 30.445 36,891 4,985 30.445 151,768 40 7.780 1,218 |
The Group’s exposure to foreign currency risk arises from the translation of the foreign currency exchange gains and losses on cash and cash equivalents, trade and other receivables, financial assets at fair value through other comprehensive income, and trade and other payables that are denominated in foreign currency.
A strengthening (weakening) of 0.5%of the NTD against the USD, and CNY as at Nine Months of 2025 and 2024 would have increased (decreased) the net profit after tax by
(Continued)
29
$1,096 thousand and $4,060 thousand, and the equity by $148 thousand and $162 thousand. The analysis is performed on the same basis.
Since the Group has many kinds of functional currency, the information on foreign exchange gain (loss) on monetary items is disclosed by total amount. For the Nine Months ended September 30, 2025 and 2024, the foreign exchange gain (loss) (including realized and unrealized portions) amounted to $37,870 thousand and $156 thousand, respectively.
(ii) Interest rate analysis
Please refer to the notes on liquidity risk management and interest rate exposure of the Group's financial assets and liabilities.
The following sensitivity analysis is based on the exposure to the interest rate risk of derivative and non-derivative financial instruments on the reporting date. Regarding assets with variable interest rates, the analysis is based on the assumption that the amount of assets outstanding at the reporting date was outstanding throughout the year. The rate of change is expressed as the interest rate increases or decreases by 0.5% when reporting to management internally, which also represents the Group management's assessment of the reasonably possible interest rate change.
If the interest rate had increased / decreased by 0.5% basis points, the Group’s net income would have increased / decreased by $0 thousand and $9 thousand for the Nine Months ended September 30, 2025 and 2024, respectively, with all other variable factors remaining constant. This is mainly due to the Group’s borrowing at variable rates.
(iii) Other market price risk
For the Nine Months ended September 30, 2025 and 2024, the sensitivity analyses for the changes in the securities price at the reporting date were performed using the same basis for profit or loss as illustrated below:
| For the Nine Months ended September 30, 2025 2024 Prices of securities at the reporting date Other comprehensive income after tax Net income Other comprehensive income after tax Net income |
For the Nine Months ended September 30, | For the Nine Months ended September 30, | For the Nine Months ended September 30, | For the Nine Months ended September 30, | For the Nine Months ended September 30, |
|---|---|---|---|---|---|
| 2025 2024 |
|||||
| Net income Other comprehensive income after tax |
Net income | ||||
| 0.5% increase $ 0.5% decrease $ |
22 (22) |
886 (886) |
86 (86) |
62 (62) |
-
Fair value of financial instruments
-
(i) Fair value hierarchy
The carrying amount and fair value of the Group’s financial assets and liabilities, including the information on fair value hierarchy were as follows; however, except as described in the following paragraphs, for financial instruments not measured at fair value whose carrying amount is reasonably close to the fair value, and lease liabilities, disclosure of fair value information is not required:
(Continued)
30
| Financial assets at fair value through profit or loss Shares of stock of overseas listed companies Beneficiary certificates Subtotal Financial assets at fair value through other comprehensive income Foreign corporate bonds Stocks in unlisted companies Subtotal Financial assets measured at amortized cost Cash and cash equivalents Trade receivables and notes receivable (including related parties) Other receivables Guarantee deposits paid (Recognition of other non-current assets) Domestic and foreign time deposits Subtotal Total Financial liabilities measured at amortized cost Trade payables Other payables Lease liabilities (including non- current) Guarantee deposits received (Recognition of other non-current liabilities) Total |
September 30, 2025 | September 30, 2025 | September 30, 2025 | |||
|---|---|---|---|---|---|---|
| Book Value | Fair Value | Total 221,499 773 |
||||
| Level 1 | Level 2 - - |
Level 3 - - |
||||
| $ 221,499 773 |
221,499 773 |
|||||
| 222,272 | 222,272 | - |
- | 222,272 | ||
| 36,891 4,499 |
- - |
36,891 4,499 |
- - |
36,891 4,499 |
||
| 41,390 | - | 41,390 | - |
41,390 | ||
| 405,527 168,763 8,689 1,395 12,107 |
- - - |
- - - |
- - - |
- - - |
||
596,481 |
||||||
$ 860,143 |
222,272 | 41,390 |
- |
263,662 |
||
$ 152,626 37,911 5,156 4,792 |
- - - - |
- - - - |
- - - - |
- - - - |
||
$ 200,485 |
(Continued)
31
| Financial assets at fair value through profit or loss Shares of stock of overseas listed companies Beneficiary certificates Subtotal Financial assets at fair value through other comprehensive income Foreign corporate bonds Stocks in unlisted companies Subtotal Financial assets measured at amortized cost Cash and cash equivalents Trade receivables and notes receivable (including related parties) Other receivables Guarantee deposits paid (Recognition of other non-current assets) Subtotal Total Financial liabilities measured at amortized cost Trade payables Other payables Lease liabilities (including non- current) Guarantee deposits received (Recognition of other non-current liabilities) Total |
December 31, 2024 | December 31, 2024 | December 31, 2024 | December 31, 2024 | Total 131,805 770 |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value $ 131,805 770 132,575 38,682 17,185 |
Fair | Value | ||||||||
| Level 1 131,805 770 |
Level 2 - - - 38,682 17,185 |
Level 3 - - |
||||||||
| 132,575 - - |
- | 132,575 38,682 17,185 |
||||||||
38,682 17,185 |
- - - - - - |
|||||||||
55,867 |
- | 55,867 |
55,867 |
|||||||
564,394 141,003 4,218 1,413 |
- - - |
- - - |
- - - |
|||||||
711,028 |
||||||||||
| $ | 899,470 |
132,575 | 55,867 | 188,442 | ||||||
| $ | 131,353 219,520 7,900 4,653 |
- - - - |
- - - - |
- - - - |
- - - - |
|||||
| $ | 363,426 |
(Continued)
32
| Financial assets at fair value through profit or loss Shares of stock of overseas listed companies Beneficiary certificates Subtotal Financial assets at fair value through other comprehensive income Foreign corporate bonds Stocks in unlisted companies Subtotal Financial assets measured at amortized cost Cash and cash equivalents Trade receivables and notes receivable (including related parties) Other receivables Guarantee deposits paid (Recognition of other non-current assets) Subtotal Total Financial liabilities measured at amortized cost Bank loans Trade payables Other payables Lease liabilities (including non- current) Guarantee deposits received (Recognition of other non-current liabilities) Total |
September 30, 2024 | September 30, 2024 | September 30, 2024 | September 30, 2024 | September 30, 2024 | September 30, 2024 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book | Value | Fair Value | Total 15,374 812 16,186 |
|||||||||
| Level 1 | Level 2 - - - 40,581 17,153 |
Level 3 | ||||||||||
| $ |
15,374 812 |
15,374 812 16,186 |
- - - - - |
|||||||||
| 16,186 | ||||||||||||
40,581 17,153 |
- - |
40,581 17,153 |
||||||||||
57,734 |
- |
57,734 |
- | 57,734 |
||||||||
631,770 134,366 3,021 1,404 |
- - - |
- - - |
- - - |
- - - |
||||||||
$ |
770,561 |
|||||||||||
| 844,481 | 16,186 | 57,734 | 73,920 | |||||||||
| $ | 3,000 126,668 215,563 8,503 4,752 |
- - - - - |
- - - - - |
- - - - - |
- - - - - |
|||||||
| $ | 358,486 |
(ii) Valuation techniques for financial instruments measured at fair value
A financial instrument is regarded as being quoted in an active market if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service, or regulatory agency and those prices represent actual and regularly occurring market transactions on an arm’s-length basis. Whether transactions are taking place ‘regularly’ is a matter of judgment and depends on the facts and circumstances of the market for the instrument.
Quoted market prices may not be indicative of the fair value of an instrument if the activity in the market is infrequent, the market is not well-established, only small volumes are traded, or bid-ask spreads are very wide. Determining whether a market is active involves judgment.
(Continued)
33
Measurements of fair value of financial instruments without an active market are based on valuation technique or quoted price from a competitor. Fair value, measured by using valuation technique that can be extrapolated from either similar financial instruments or discounted cash flow method or other valuation techniques, including models, is calculated based on available market data at the reporting date.
- (iii) Transfers between Level 1 and Level 2
There were no transfers from level 2 to level 1 for the Nine Months ended September 30, 2025 and 2024.
- (r)Financial risk management
There were no significant changes in the Group's financial risk management and policies as disclosed in note6(r) to the consolidated financial statements for the year ended December 31, 2024.
- (s) Capital management
Management believes that the objectives, policies and processes of capital management of the Group has been applied consistently with those described in the consolidated financial statements for the year ended December 31, 2024. Also, management believes that there were no significant changes in the Group's capital management information as disclosed for the year ended December 31, 2024. Please refer to note6(s) to the consolidated financial statements for the year ended December 31, 2024 for further details.
- (t) Investing and financing activities not affecting the current cash flow
To obtain the right to use assets through a leasing arrangement, please refer to note 6(g).
7. Related-party transactions
- (a) Names and relationships with related parties
The followings are entities that have had transactions with related party during the periods covered in the consolidated financial statements.
Name of related party Relationship with the Group Lin, I-Chin Chairman of this company LIN, WEN-TENG Director of this company Sunrise On The Bund The chairman of the subsidiary is the same as the chairman of the Hotel(Sunrise) Company. PU HWUA ENTERPRISE CO., The chairman of the subsidiary is the same as the chairman of the LTD.(Pu Hwua) Company. Juyang Xingye Industrial Co., The chairman of the Company is also a director of the subsidiary. Ltd. ( Juyang Xingye)
Juiye Enterprise Co., Ltd.(Juiye The chairman of the company is a director of the company. Enterprise)
(Continued)
34
(b) Significant transactions with related parties
1. Sales
The amounts of significant sales by the Group to related parties were as follows:
| Other related parties | For the three months ended September 30 2025 2024 $ 653 875 |
For the Nine Months ended September 30 |
For the Nine Months ended September 30 |
|---|---|---|---|
| 2025 $ 653 |
2025 **3,420 ** |
2024 2,572 |
The sales price of the group to the related party is not significantly different from the general selling price. The average credit period for related parties as of September 30, 2025, and January 1 to September 30, 2024, is approximately 120 days, while for general customers, it ranges from 30 to 90 days.
- Receivables from related parties
The receivables from related parties were as follows:
| Account Trade receivables |
Relationship Other related parties |
September 30, 2025 $ 505 |
December 31, 2024 1,812 |
September 30, 2024 |
|---|---|---|---|---|
| 588 |
- Payables to related parties
The payables to related parties were as follows:
| Account Other payables |
Relationship Others |
September 30, 2025 $ 49 |
December 31, 2024 26 |
September 30, 2024 358 |
|---|---|---|---|---|
4. Leases
The Group collected rental income from other related parties and affiliated companies, reporting lease income of $442 thousand, $440 thousand, $1,323 thousand and $1,300 thousand for the three months and the Nine Months ended September 30, 2025 and 2024 respectively. As of September 30, 2025, December 31, 2024, and September 30, 2024, related rental deposits amounted to $270 thousand, $270 thousand and $405 thousand respectively.
In November 2022, the Group rented an office building from the Key management person to be used as its headquarter. A five-year lease contract was signed, in which the rental fee is determined based on nearby office rental rates. The total value of the contract was $5,309 thousand. For the three months and the Nine Months ended September 30, 2025, and 2024 respectively, the Group recognized the amounts of $18 thousand, $29 thousand, $63 thousand and $92 thousand as interest expenses. As of September 30, 2025 and 2024 respectively the balance of lease liabilities amounted to $2,073 thousand, $3,029 thousand and $3,292 thousand.
5. Prepayments
| Account Prepayments |
Relationship Sunrise |
September 30, 2025 $ 3,425 |
December 31, 2024 3,138 |
September 30, 2024 5,398 |
|---|---|---|---|---|
(Continued)
35
6. Other
The combined company's operating expenses related to other related parties the three months and the Nine Months ended September 30, 2025, and 2024 were $2,089 thousand, $5,103 thousand, $6,153 thousand, and $6,328 thousand, respectively.
(a) Others
In case of registering real estate under the name of other related parties, please refer to Note 6(7) for details.
(b) Key management personnel compensation
Key management personnel compensation comprised:
| Short-term employee benefits Post-employment benefits |
For the three months ended September 30 2025 2024 $ 3,463 3,813 47 48 $ 3,510 3,861 |
For the Nine Months ended September 30 |
For the Nine Months ended September 30 |
|---|---|---|---|
| 2025 $ 3,463 47 $ 3,510 |
2025 10,629 137 **10,766 ** |
2024 | |
14,518 172 |
|||
14,690 |
8. Assets pledged as security
The carrying amounts of assets pledged as security were as follows:
| Assets pledged as security Property, plant and equipment Investment property |
Liabilities secured by pledge Long-term borrowings Long-term borrowings |
September 30, 2025 $227,199 48,683 $275,882 |
December 31, 2024 229,510 49,507 279,017 |
September 30, 2024 |
|---|---|---|---|---|
| 230,286 49,781 |
||||
| 280,067 |
9. Significant Commitments and Contingencies
- (a) Unrecognized contractual commitments
As of September 30, 2025, December 31, 2024, and September 30, 2024, the detailed amounts of the contract prices for equipment and construction projects entered into by the Group with suppliers are as follows:
| Signed-contract Paid-price |
September 30, 2025 $ 68,987 $ 23,150 |
December 31, 2024 259,598 50,971 |
September 30, 2024 |
|---|---|---|---|
| 262,830 | |||
| 61,225 |
(b) In September 2023, the subsidiary Zhejiang Rectron signed a relocation compensation agreement with Jiashan Economic Development Zone Asset Management Co., Ltd., based on the strategic transformation needs of its industrial park. The agreed compensation amount was $690,785 thousand (RMB 161,653 thousand), and a signing bonus of $345,395 thousand (RMB 80,827 thousand) was received in the same year. In March 2025, the Company received $170,520 thousand (RMB 39,904 thousand). As of September 30, 2025, the total amount received was $515,915 thousand (RMB 120,731 thousand), which was recorded under other current liabilities. In addition, relocation expenses of $1,111 thousand (RMB 260 thousand) incurred during the current period were deducted from the proceeds in accordance with the relocation compensation agreement.
(Continued)
36
10. Losses due to major disasters: none
11. Subsequent events: none
12. Others
- (a) A summary of employee benefits, depreciation, and amortization, by function, is as follows:
| By function By item |
For the | three months ended September 30, | three months ended September 30, | three months ended September 30, | ||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Cost of sales |
Operating expenses |
Total | Cost of sales |
Operating expenses |
Total | |
| Employee benefits Salary Labor and health insurance Pension Others Depreciation Amortization |
8,404 322 117 165 9,902 142 |
22,167 1,907 1,126 1,331 3,557 147 |
30,571 2,229 1,243 1,496 13,459 289 |
8,600 319 119 137 9,692 122 |
21,738 2,234 1,087 1,109 2,839 626 |
30,338 2,553 1,206 1,246 12,531 748 |
| By function By item |
For the Nine Months ended September 30, | For the Nine Months ended September 30, | For the Nine Months ended September 30, | For the Nine Months ended September 30, | ||
|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||
| Cost of sales |
Operating expenses |
Total | Cost of sales |
Operating expenses |
Total | |
| Employee benefits Salary Labor and health insurance Pension Others Depreciation Amortization |
20,996 992 352 415 30,165 344 |
67,434 6,034 3,497 3,907 9,209 370 |
88,400 7,026 3,849 4,322 39,374 714 |
21,629 1,004 377 418 28,878 363 |
64,970 5,976 3,414 3,168 8,268 1,922 |
86,599 6,980 3,791 3,586 37,146 2,285 |
(b) Seasonality of operations
The Group's operations were not affected by seasonality or cyclicality factors.
13. Other disclosure items
(a) Information on significant transaction:
The followings were the information on significant transactions required by the “Regulations Governing the Preparation of Financial Reports by Securities Issuers” for the Group for the Nine Months ended September 30, 2025:
1. Lending to other parties:
==> picture [426 x 71] intentionally omitted <==
----- Start of picture text -----
Highest
balance Collateral
of Actual Transaction
financing usage Range of Purposes amount for Reasons Allowance
to other amount interest of fund business for short- for bad Individual Maximum
Number Name of lender borrower Name of Account name Related party parties during the balance Ending during period the during the period rates financing borrower for the two parties between financing term debt Item Value loan limits funding financing limit of fund
period
1 Rectron China CHU-TING Other Yes 189,775 93,771 93,771 - 2 - Operation - - - 355,615 355,615
receivables (note 4) Requirements
----- End of picture text -----
Note 1: For business transactions with counterparties, the business transaction amount is determined based on the cumulative sales (or purchases) amount between the two parties over the preceding twelve months.
Note2: According tour policy, the calculation for the maximum total amount of loans granted are as follows:
(1) The Company
Individual counterparty funding limit = Shareholders' equity x 40% = $1,793,215thousand x40% = $717,286thousand.
The maximum funding limit for an individual counterparty = Shareholders' equity x 40% = $1,793,215thousand x 40% = $717,286 thousand.
(2) Rectron Electronics (China)
Individual counterparty funding limit = Shareholders' equity x 500% = $71,123 thousand x 500% = $355,615 thousand.
(Continued)
37
The maximum funding limit for an individual counterparty = Shareholders' equity x 500% = $71,123 thousand x 500% = $355,615 thousand.
Note3: Already eliminated during the preparation of the consolidated financial statements.
Note 4: (1) Business transaction with counterparts exists.
-
(2) Short-term funding is necessary.
-
Guarantees and endorsements for other parties: None.
-
Information regarding securities held at the reporting date (subsidiaries, associates and joint ventures not included):
(Amounts in Thousands of New Taiwan Dollar)
| Company holding securities | Security type and name |
Relationship with the Company |
Account | September 30, 2025 | September 30, 2025 | September 30, 2025 | Remark | |
|---|---|---|---|---|---|---|---|---|
| Shares | Carrying value |
Percentage of ownership (%) |
Market value ( or net value) |
|||||
| The Company | Stock - Sunny Bank | - | Non-current financial assets at fair value through other comprehensive income |
490,111 | 4,499 | 0.01% | 4,499 | |
| The Company | Corporate bonds – Apple | - | Non-current financial assets at fair value through other comprehensive income |
- | 24,341 | -% | 24,341 | |
| The Company | Corporate bonds – AT&T | - | Non-current financial assets at fair value through other comprehensive income |
- | 8,796 | -% | 8,796 | |
| The Company | Corporate bonds – Pfizer | - | Non-current financial assets at fair value through other comprehensive income |
- | 3,754 | - % | 3,754 | |
| CHU-TING | Fund – Yuan ta High Dividend 0056 | - | Current financial assets at fair value through profit or loss |
21,000 | 773 | -% | 773 | |
| CHU-TING | Stock - LMT | - | Current financial assets at fair value through profit or loss |
9,550 | 145,145 | - % | 145,145 | |
| CHU-TING | Stock - NVDA | - | Current financial assets at fair value through profit or loss |
6,160 | 34,991 | - % | 34,991 | |
| Rectron China | Stock - NVDA | - | Current financial assets at fair value through profit or loss |
7,500 | 41,363 | - % | 41,363 | |
| Rectron China | Fixed Deposit Certificate – Bank of Communications (Singapore Branch) |
- | Current financial assets measured at amortized cost |
12,107 | - % | 12,107 |
- Information regarding related-party purchases and/or sales exceeding 100 million or 20% of the Company’s paid-in capital:
| (Amounts in Thousands of New Taiwan Dollar) | (Amounts in Thousands of New Taiwan Dollar) | (Amounts in Thousands of New Taiwan Dollar) | (Amounts in Thousands of New Taiwan Dollar) | (Amounts in Thousands of New Taiwan Dollar) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Company name | Related party | Nature of relationship | Transaction details | Abn trans |
ormal action |
Trade receivables (payables) and notes receivable (payable) |
Remark | ||||
| Item | Amount | Percentage of the purchases (sales) (%) |
Payment term |
Unit price |
Payment terms |
Ending balance |
Percentage of total receivables (payables) |
||||
| The Company Rectron China Rectron China Zhejiang Rectron |
Rectron China The Company Zhejiang Rectron Rectron China |
Parent-subsidiary relationship Parent-subsidiary relationship Investee companies that are also evaluated using the equity method by the Company Investee companies that are also evaluated using the equity method bythe Company |
Purchase Sales Purchase Sales |
278,526 (278,526) 336,969 (336,969 |
76% (75%) 100 % (78 %) |
Normal Normal Normal Normal |
Normal Normal Normal Normal |
90-120 Days 90-120 Days 120 Days 120 Days |
(20,443) 20,443 (76,803) 76,803 |
(34)% 99% (100)% 82% |
Note: The amount had been offset in the consolidated financial statements.
- Information regarding receivables from related parties exceeding 100 million or 20% of the
Company’s paid-in capital: None.
(Continued)
38
- Significant transactions and business relationship between the parent company and its subsidiaries for the Nine Months ended September 30, 2025:
(Amounts in Thousands of New Taiwan Dollar)
| No. (Note 1) |
Company name | Counterparty | Relationship (Note 2) |
Intercompany transactions | Intercompany transactions | ||
|---|---|---|---|---|---|---|---|
| Account | Amount | Terms | Percentage of total consolidated net sales or assets |
||||
| 0 | Rectron Ltd. | Rectron China | 1 | Operating cost | 278,526 | Calculated with finished product cost plus agreedprofit. |
44 |
| 0 | Rectron Ltd. | Rectron China | 1 | Trade payables | 20,443 | Adjusted according to the overall funding situation between the parent and subsidiary companies, with a term of 120 days as stipulated in the agreement. |
1% |
| 0 | Rectron Ltd. | REEI | 1 | Operating revenue | 41,995 | Calculated with finished product cost plus agreedprofit. |
7% |
| 0 | Rectron Ltd. | REEI | 1 | Trade receivable | 14,474 | Adjusted according to the overall funding situation between the parent and subsidiary companies, with a term of 120 days as stipulated in the agreement. |
1% |
| 1 | Rectron China | Zhejiang Rectron | 3 | Operating cost | 336,969 | Calculated with finished product cost plus agreedprofit. |
53% |
| 1 | Rectron China | Zhejiang Rectron | 3 | Trade payables | 76,803 | Adjusted according to the overall funding situation between the parent and subsidiary companies, with a term of 120 days as stipulated in the agreement. |
3% |
| 2 | CHU-TING | Rectron China | 3 | Other payables | 93,771 | Adjusted according to the overall funding situation between the parent and subsidiary companies, with a term of 120 days as stipulated in the agreement. |
4% |
Note 1: Companies are numbered as follows: Parent company - 0 Subsidiary - starting from 1
Note 2: The relationships between transaction parties are numbered as follows: Parent company and subsidiary - 1
Subsidiary and parent company - 2 Subsidiary and subsidiary - 3
(b) Information on investments:
The followings are the information on investees for the Nine Months ended September 30, 2025:
(Amounts in Thousands of New Taiwan Dollar)
| Name of investor |
Name of investee |
Location | Main businesses | Original i am |
nvestment ount |
Balance a | s of September 30, 2025 | s of September 30, 2025 | Net income (loss) of the investee |
Investment income (loss) recognised by the Company |
Remark |
|---|---|---|---|---|---|---|---|---|---|---|---|
| September 30, 2025 |
December 31, 2024 |
Shares |
Percentage | Carrying value |
|||||||
| The Company | REEI | USA | Sales of rectifiers, etc. Electronic components |
142,264 | 142,264 | 205,000 | 100.00% | 1,658 | (3,810) | (3,810) |
|
| The Company | Rectron China | Hong Kong |
Sales of rectifiers, etc. Electronic components |
282,573 | 282,573 | 20,000 | 100.00% | 71,123 | 1,560 | 1,560 | |
| The Company | CHU-TING | Taiwan | Wholesale of tobacco and alcohol products and manufacturing and sales of medical equipment. |
164,987 |
109,987 | 20,000,000 | 100.00% | 212,481 | 3,348 | 3,348 |
Note: The amount had been offset in the consolidated financial statements.
(c) Information on investment in Mainland China:
- Name of the investee in Mainland China, principal business activities, and other relevant information:
(Amounts in Thousands of New Taiwan Dollar)
| Investee | Main businesses and products |
Total amount of paid-in capital |
Method of investment |
Accumulated outflow of investment from Taiwan as of January 1, 2025 |
Inves | tment | Accumulated outflow of investment from Taiwan as of September 30, 2025 |
Net income (losses) of the investee |
Percentage of ownership |
Investment income (loss) recognized |
Carrying value as of September 30, 2025 |
Accumulated inward remittance of earnings as of September 30, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outflow |
Inflow | |||||||||||
| Zhejiang Rectron | Manufacturing and sales of rectifiers and other electronic components. |
64,940 USD2,000 (Note1) |
NOTE 1(3) | 409,029 USD12,000 |
- | 340,857 USD10,000 |
68,172 USD2,000 |
459 | 100.00% | 459 | (9,411) | - |
Note1: Zhejiang Rectron completed a capital reduction registration with the industrial and commercial authorities on November 15, 2024, reducing its capital by USD 10,000 thousand. The original investment amount was adjusted using the exchange rate of 32.47 on that date. The amount was repatriated to the Company on January 2, 2025, at an exchange rate of 32.865. The capital reduction was approved by the Investment Commission of the Ministry of Economic Affairs on May 13, 2025.
(Continued)
39
2. Upper limit on investment in Mainland China:
| (Amounts in Thousands of New Taiwan Dollar) Investment amount authorized by Investment Commission, MOEA Upper limit on investment 181,757 USD5,970 1,075,929 |
(Amounts in Thousands of New Taiwan Dollar) Investment amount authorized by Investment Commission, MOEA Upper limit on investment 181,757 USD5,970 1,075,929 |
|
|---|---|---|
| Accumulated investment in Mainland China as of September 30, 2025 |
Investment amount authorized by Investment Commission, MOEA |
Upper limit on investment |
| 60,890 USD 2,000 |
181,757 USD5,970 |
1,075,929 |
-
Note 1: Investment methods are categorized into the following three types, simply indicated by their types:
-
(1)Direct investment in mainland China.
-
(2)Investment in Mainland China through a third-party company in another region (please specify the investment company in that third region).
-
(3)Others method.
-
Note 2: In the investment gains/losses recognized in this period column:
-
(1)If it is under preparation and there are no investment gains/losses yet, it should be noted.
-
(2)The basis for recognizing investment gains/losses is the financial statements audited and certified by the certified public accountant of the Taiwan parent company.
-
Note 3: According to the "Principles for Reviewing Investment or Technical Cooperation in Mainland China," there are limits to the amount of investment.
Equity net worth × 60% = $1,793,215 thousand × 60% = $1,075,929 thousand.
- Note 4: Zhejiang Rectron completed a capital reduction registration with the industrial and commercial authorities on November 15, 2024, reducing its capital by USD 10,000 thousand, and the amount was repatriated to the Company on January 2, 2025. The capital reduction was approved by the Investment Commission of the Ministry of Economic Affairs on May 13, 2025.
3. Significant transactions:
The significant inter-company transactions with the subsidiary in Mainland China, which were eliminated in the preparation of consolidated financial statements, are disclosed in "Information on significant transactions”.
14. Segment information
(a) General information
The consolidated company has four reporting segments: Electronics, Real Estate Investment, Medical Equipment, and Wine Trading. The Diode segment is engaged in the manufacturing and sales of various rectifiers and other semiconductor components. The Real Estate Investment segment is engaged in the business of leasing office buildings and factories. The Medical Equipment segment is engaged in the business of buying and selling and manufacturing masks. The Wine Trading segment is engaged in the business of trading red and white wines.
The reporting segments of the consolidated company are strategic business units that provide different products and services. As each strategic business unit requires different technology and marketing strategies, they need to be managed separately.
- (b) Information of profit or loss, assets, liabilities, basis and adjustments of which of departments to be reported.
The consolidated company uses the departmental pre-tax profit (excluding non-recurring gains and losses and exchange gains and losses) reviewed by the chief operating decision-maker in the internal management report as the basis for resource allocation and performance evaluation by the management. Since income tax, non-recurring gains and losses, and exchange gains and losses are managed on a group basis, the consolidated company does not allocate income tax expenses (benefits), non-recurring gains and losses, and exchange gains and losses to the reporting segments. In addition, not all significant non-cash items, other than depreciation and amortization, are included in the income statement of all reporting segments. The amounts reported are consistent with the reports used by the operating decision-makers.
The information and adjustments for the operating segments of the consolidated company are as follows: The Group’s operating segment information and reconciliation are as follows:
(Continued)
| For the three months ended September 30, 2025 Revenue Revenue from external customers Intersegment revenues Total revenue Reportable segment profit or loss For the three months ended September 30, 2024 Revenue Revenue from external customers Intersegment revenues Total revenue Reportable segment profit or loss For the Nine Months ended September 30, 2025 Revenue Revenue from external customers Intersegment revenues Total revenue Reportable segment profit or loss For the Nine Months ended September 30, 2024 Revenue Revenue from external customers Intersegment revenues Total revenue Reportable segment profit or loss |
Electronics Department $ 216,815 121,530 $338,345 $43,557 Electronics Department $ 192,965 176,274 $369,239 $26,472 Electronics Department $ 607,807 654,858 $1,262,665 $110,510 Electronics Department $ 526,051 462,804 $988,855 $ 94,696 |
Property Management Division 5,172 - 5,172 3,479 Property Management Division 6,016 - 6,016 3,998 Property Management Division 16,509 - 16,509 11,065 Property Management Division 17,139 - 17,139 11,070 |
Medical Devices Division 1,810 51 1,861 (1,413) Medical Devices Division 1,972 38 2,010 (958) Medical Devices Division 6,754 288 7,042 (4,631) Medical Devices Division 6,768 252 7,020 (3,781) |
Wine Trading Department 626 - 626 205 Wine Trading Department 846 - 846 139 Wine Trading Department 3,354 - 3,354 800 Wine Trading Department 2,519 - 2,519 373 |
Other Department 23,116 Other Department (12,651) Other Department - (29,872) Other Department - (22,724) |
40 (Continued) Reconciliation and elimination Total - 224,423 (121,581) - (121,581) 224,423 - 68,994 Reconciliation and elimination Total - 201,799 (176,312) - (176,312) 201,799 - 17,000 Reconciliation and elimination Total - 634,424 (655,146) - (655,146) 634,424 - 87,872 Reconciliation and elimination Total - 552,477 (463,056) - (463,056) 552,477 - 79,634 |
40 **Total ** |
|
|---|---|---|---|---|---|---|---|---|
| 224,423 - |
||||||||
| 224,423 | ||||||||
| 68,994 | ||||||||
| **Total ** | ||||||||
| 201,799 - |
||||||||
| 201,799 | ||||||||
| 17,000 | ||||||||
| **Total ** | ||||||||
| 634,424 - |
||||||||
| 634,424 | ||||||||
| 87,872 | ||||||||